Abacavir, Lamivudine and Zidovudine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Abacavir, Lamivudine and Zidovudine, covering 2013-12-05 to 2022-04-06. Get the full timeline:
Most recent: FDA Approved: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)